N-oxydiethylenethiocarbamoyl-N-oxydiethylene sulfenamide: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 83700 |
| SCHEMBL ID | 3137085 |
| MeSH ID | M0101958 |
| Synonym |
|---|
| 4-[(morpholin-4-ylcarbonothioyl)thio]morpholine |
| n-oxydiethylene thiocarbamyl- n-oxydiethylene sulfenamide |
| 13752-51-7 |
| n-oxydiethylenethiocarbamoyl-n-oxydiethylene sulfenamide |
| 4-((morpholinothio)thioxomethyl)morpholine |
| n-oxydiethylene thiocarbamyl-n-oxydiethylene sulfenamide |
| einecs 237-335-9 |
| n-oxydiethylenethiocarbamyl-n-oxydiethylene sulfenamide |
| n-oxydiethylene thiocarbamyl-n'-oxydiethylene sulfenamide |
| cure-rite 18 |
| n-oxydiethylenethiocarbamyl-n'-oxydiethylenesulfenamide |
| morpholine, 4-((morpholinothiocarbonyl)thio)- |
| otos |
| morpholine, 4-((4-morpholinylthio)thioxomethyl)- |
| 4-((morpholinothiocarbonyl)thio)morpholine |
| brn 1214828 |
| 4-((4-morpholinylthio)thioxomethyl)morpholine |
| TIMTEC1_000313 |
| morpholine, 4-[(4-morpholinylthio)thioxomethyl]- |
| NCGC00175247-01 |
| accelerator otos |
| HMS1534O05 |
| morpholin-4-yl morpholine-4-carbodithioate |
| A807271 |
| unii-w5dxw9jf2g |
| w5dxw9jf2g , |
| 4-morpholinecarbodithioic acid, 4-morpholinyl ester |
| ec 237-335-9 |
| AKOS015913902 |
| HOEFWOBLOGZQIQ-UHFFFAOYSA-N |
| SCHEMBL3137085 |
| 4-[(morpholinothio)thioxomethyl]morpholine |
| W-110352 |
| DTXSID5021095 , |
| 4-[(4-morpholinylthio)thioxomethyl]-morpholine |
| FT-0703648 |
| 4-morpholinecarbodithioic acid 4-morpholinyl ester |
| Q26840937 |
| acceleratorotos |
| morpholino morpholine-4-carbodithioate |
| 4-[(morpholinothio)thiocarbonyl]morpholine |
| morpholine, 4-[(morpholinothiocarbonyl)thio]- |
| oxydiethylene thiocarbamyl-n-oxydiethylene sulfenamide, n- |
| n-oxydiethylenethiocarbamoyl-n'-oxydiethylenesulfenamide |
| n,n:n',n'-bis(oxydiethylene)thiocarbamoylsulfenamide |
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID588519 | A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities | 2011 | Antiviral research, Sep, Volume: 91, Issue:3 | High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors. |
| AID540299 | A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis | 2010 | Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21 | Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 4 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.38) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||